IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR Cortiment® 9mg prolonged release tablets (budesonide)

  • Cortiment® 9mg prolonged release tablets, manufactured by Ferring Pharmaceuticals, were launched in the UK in April 2015. UKMI has assessed this new product using the UKMI product safety tool.
  • The product is licensed for inducing remission in mild to moderate active ulcerative colitis in adults for whom aminosalicylate treatment is not sufficient. It is one of three brands of oral budesonide available the UK.
BudesonideGastrointestinal disordersMedicineNew Medicines

Attachments